Kenya Shitara
About
Kenya Shitara is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology.
According to data from OpenAlex, Kenya Shitara has authored 86 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 53 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Immunology. Recurrent topics in Kenya Shitara's work include Glycosylation and Glycoproteins Research (53 papers), Monoclonal and Polyclonal Antibodies Research (53 papers) and Galectins and Cancer Biology (13 papers). Kenya Shitara is often cited by papers focused on Glycosylation and Glycoproteins Research (53 papers), Monoclonal and Polyclonal Antibodies Research (53 papers) and Galectins and Cancer Biology (13 papers). Kenya Shitara collaborates with scholars based in Japan, Singapore and United States. Kenya Shitara's co-authors include Mitsuo Satoh, Kazuyasu Nakamura, Kazuhisa Uchida, Nobuo Hanai, Shigeru Iida, Rinpei Niwa, Masako Wakitani, Yutaka Kanda, Toyohide Shinkawa and Mikito Ito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.
In The Last Decade
Kenya Shitara
85 papers receiving 7.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kenya Shitara Japan | 42 | 5.6k | 4.3k | 2.8k | 1.3k | 571 | 86 | 7.7k | ||
| Dorothee Herlyn United States | 46 | 3.9k 0.7× | 3.8k 0.9× | 3.2k 1.1× | 3.3k 2.4× | 597 1.0× | 154 | 8.4k | ||
| Gerhard Moldenhauer Germany | 52 | 3.4k 0.6× | 1.8k 0.4× | 2.9k 1.0× | 2.7k 2.0× | 284 0.5× | 129 | 7.6k | ||
| Alan F. Wahl United States | 36 | 3.1k 0.6× | 2.0k 0.5× | 1.1k 0.4× | 3.3k 2.4× | 236 0.4× | 64 | 6.9k | ||
| B M Fendly United States | 39 | 3.5k 0.6× | 3.0k 0.7× | 1.5k 0.5× | 3.9k 2.9× | 171 0.3× | 59 | 7.6k | ||
| Maria I. Colnaghi Italy | 40 | 2.1k 0.4× | 1.8k 0.4× | 1.5k 0.5× | 1.8k 1.3× | 209 0.4× | 171 | 4.8k | ||
| Keith C. Robbins United States | 48 | 5.1k 0.9× | 1.0k 0.2× | 1.6k 0.6× | 1.8k 1.4× | 241 0.4× | 94 | 8.1k | ||
| Roger R. Beerli Switzerland | 34 | 4.0k 0.7× | 2.1k 0.5× | 889 0.3× | 2.6k 2.0× | 183 0.3× | 52 | 6.3k | ||
| Yukinari Kato Japan | 50 | 3.9k 0.7× | 1.5k 0.4× | 2.5k 0.9× | 6.2k 4.6× | 269 0.5× | 420 | 10.6k | ||
| S A Aaronson United States | 46 | 5.8k 1.0× | 1.3k 0.3× | 1.1k 0.4× | 3.1k 2.3× | 254 0.4× | 98 | 9.6k | ||
| Robert L. Shields United States | 20 | 2.5k 0.4× | 2.4k 0.6× | 1.5k 0.5× | 465 0.3× | 279 0.5× | 28 | 4.3k |
Countries citing papers authored by Kenya Shitara
Since
Specialization
Citations
This map shows the geographic impact of Kenya Shitara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenya Shitara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenya Shitara more than expected).
Fields of papers citing papers by Kenya Shitara
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kenya Shitara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenya Shitara. The network helps show where Kenya Shitara may publish in the future.
Co-authorship network of co-authors of Kenya Shitara
This figure shows the co-authorship network connecting the top 25 collaborators of Kenya Shitara. A scholar is included among the top collaborators of Kenya Shitara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenya Shitara. Kenya Shitara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sugimoto, Yoshiyuki, Kazuhiro Yoshikawa, Makoto Sumitomo, et al.. (2014). The therapeutic potential of a novel PSMA antibody and its IL-2 conjugate in prostate cancer.. PubMed. 34(1). 89–97.
2.
Shitara, Kenya, et al.. (2010). Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc +/− Mice. Molecular Cancer Therapeutics. 9(2). 419–428.
3.
Kubota, Tsuguo, Rinpei Niwa, Mitsuo Satoh, et al.. (2009). Engineered therapeutic antibodies with improved effector functions. Cancer Science. 100(9). 1566–1572.
4.
Iida, S., Akira Okazaki, Keisuke Mori, et al.. (2008). The N-linked oligosaccharide at Fc RIIIa Asn-45: an inhibitory element for high Fc RIIIa binding affinity to IgG glycoforms lacking core fucosylation. Glycobiology. 19(2). 126–134.
5.
Matsumiya, S., Yoshiki Yamaguchi, Junichi Saito, et al.. (2007). Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1. Journal of Molecular Biology. 368(3). 767–779.
6.
Mori, Katsuhiro, Miho Inoue, Masako Wakitani, et al.. (2007). Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC. BMC Biotechnology. 7(1). 84–84.
7.
Kanda, Yutaka, Reiko Kuni‐Kamochi, Katsuhiro Mori, et al.. (2007). Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: A new strategy for generating completely non-fucosylated recombinant therapeutics. Journal of Biotechnology. 130(3). 300–310.
8.
Iida, Shigeru, Hirofumi Misaka, Miho Inoue, et al.. (2006). Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa. Clinical Cancer Research. 12(9). 2879–2887.
9.
Satoh, Mitsuo, Kenya Shitara, & Nobuo Hanai. (2006). The Current Stream and Prospect of Glycoscience Application-Therapeutic Antibodies-. Trends in Glycoscience and Glycotechnology. 18(100). 129–136.
10.
Natsume, Akito, Masako Wakitani, Naoko Yamane‐Ohnuki, et al.. (2006). Fucose Removal from Complex-Type Oligosaccharide Enhances the Antibody-Dependent Cellular Cytotoxicity of Single-Gene–Encoded Bispecific Antibody Comprising of Two Single-Chain Antibodies Linked to the Antibody Constant Region. The Journal of Biochemistry. 140(3). 359–368.
11.
Kobayashi, Yukari, Masako Wakitani, Kazuhisa Uchida, et al.. (2006). Enhanced Fc-Dependent Cellular Cytotoxicity of Fc Fusion Proteins Derived from TNF Receptor II and LFA-3 by Fucose Removal from Asn-Linked Oligosaccharides. The Journal of Biochemistry. 140(6). 777–783.
12.
Yamaguchi, Yoshiki, Mayumi Nagano, Hirokazu Yagi, et al.. (2005). Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochimica et Biophysica Acta (BBA) - General Subjects. 1760(4). 693–700.
13.
Niwa, Rinpei, Akito Natsume, Masako Wakitani, et al.. (2005). IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. Journal of Immunological Methods. 306(1-2). 151–160.
14.
Yamane‐Ohnuki, Naoko, Satoko Kinoshita, Shigeru Iida, et al.. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity. Biotechnology and Bioengineering. 87(5). 614–622.
15.
Okazaki, Akira, Kazuyasu Nakamura, Masako Wakitani, et al.. (2004). Fucose Depletion from Human IgG1 Oligosaccharide Enhances Binding Enthalpy and Association Rate Between IgG1 and FcγRIIIa. Journal of Molecular Biology. 336(5). 1239–1249.
16.
Ikeda, Yuika, Sumiko Abe-Dohmae, Ryo Aoki, et al.. (2003). Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochemical and Biophysical Research Communications. 311(2). 313–318.
17.
Shinkawa, Toyohide, Kazuyasu Nakamura, Yutaka Kanda, et al.. (2003). The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity. Journal of Biological Chemistry. 278(5). 3466–3473.
18.
Nakamura, Kazuyasu, Yūko Tanaka, Kenya Shitara, & Nobuo Hanai. (2001). Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions. Cancer Immunology Immunotherapy. 50(5). 275–284.
19.
Hanai, Nobuo, Kazuyasu Nakamura, & Kenya Shitara. (2000). Recombinant antibodies against ganglioside expressed on tumor cells. Cancer Chemotherapy and Pharmacology. 46(S1). S13–S17.
20.
Shitara, Kenya, et al.. (1994). A new vector for the high level expression of chimeric antibodies in myeloma cells. Journal of Immunological Methods. 167(1-2). 271–278.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dorothee Herlyn Breakdown of academic impact, for papers by Gerhard Moldenhauer Breakdown of academic impact, for papers by Alan F. Wahl Breakdown of academic impact, for papers by B M Fendly Breakdown of academic impact, for papers by Maria I. Colnaghi Breakdown of academic impact, for papers by Keith C. Robbins Breakdown of academic impact, for papers by Roger R. Beerli Breakdown of academic impact, for papers by Yukinari Kato Breakdown of academic impact, for papers by S A Aaronson Breakdown of academic impact, for papers by Robert L. Shields